CureVac N.V.

    CureVac N.V.

    XXETR:5CV
    3.89
    EUR
    0.00
    (0.00%)
    7.98P/E
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    0.07
    0.1
    0.27
    0.55
    0.36
    0.24
    2.39
    0.31
    Basic EPS, GAAP
    -0.4
    -0.57
    -0.72
    -2.21
    -1.32
    -1.18
    0.72
    0.57
    Free Cash Flow per Basic Share
    -0.5
    -0.56
    2.63
    -4.63
    -2.01
    -1.46
    0.37
    -0.56
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.18
    -0.24
    3.94
    3.68
    2.74
    2.31
    3.11
    3.87
    Tangible Book Value per Share
    0.15
    -0.28
    3.86
    3.61
    2.57
    2.18
    2.99
    3.76
    Basic Weighted Avg Shares
    176
    176
    180
    186
    189
    221
    224
    225
    Sales/Revenue/Turnover
    13
    17
    49
    103
    67
    54
    535
    71
    Operating Margin (%)
    -565.8
    -571.3
    -224.7
    -400.29
    -370
    -510.08
    33.2
    215.93
    Depreciation Expense
    4
    7
    11
    16
    24
    23
    19
    18
    Net Income, GAAP
    -71
    -100
    -129
    -412
    -249
    -260
    162
    129
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    15.03
    18.15
    Profit Margin (%)
    -553.5
    -573.46
    -264.21
    -399.76
    -369.37
    -483.96
    30.3
    182.11
    Working Capital
    45
    29
    1,142
    582
    428
    292
    454
    637
    LT Debt
    - -
    77
    27
    25
    37
    37
    34
    30
    Total Equity
    32
    -43
    711
    688
    533
    517
    697
    871
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    22.99
    14.39
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    25.06
    16.02
    Return on Common Equity (%)
    - -
    - -
    - -
    -58.82
    -40.77
    -49.55
    26.73
    16.14

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    ST Debt
    5
    5
    5
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    32
    31
    30
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    225
    225
    225
    Market Capitalization
    581
    1,029
    1,027

    Working Capital

    EUR

    •

    in mil. unless spec.
    Mar'25
    Jun'25
    Sep'25
    Total Current Assets
    469
    420
    873
    Cash, Cash Equivalents & STI
    442
    396
    419
    Accounts Receivable, Net
    2
    - -
    20
    Inventories
    1
    1
    1
    Total Current Liabilities
    61
    68
    236
    Payables & Accruals
    28
    26
    51
    ST Debt
    5
    5
    5
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    -351.2%
    34.76%
    Free Cash Flow
    - -
    -211.36%
    -125.82%
    Net Income, GAAP
    - -
    10.15%
    -162.34%
    Sales/Revenue/Turnover
    - -
    226.42%
    895.54%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    7
    8
    16
    23
    54
    2024
    12
    14
    494
    14
    535
    2025
    1
    1
    54
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.27
    -0.3
    -0.22
    - -
    -1.18
    2024
    -0.31
    -0.32
    1.51
    - -
    0.72
    2025
    -0.23
    -0.26
    1.21
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business